发明名称 |
METHOD OF SCREENING REMEDY FOR HEART FAILURE |
摘要 |
A method of screening a drug having its action point at the Ca<2+> transport controlling mechanism (Ca<2+> pump-phospholamban system) in heart muscle endoplasmic reticulum, i.e., the Ca<2+> storage site in heart muscle cells. More particularly speaking, a method of screening a drug by using the inhibition of the binding of Ca<2+> pump to phospholamban as an indication.
|
申请公布号 |
WO0216937(A1) |
申请公布日期 |
2002.02.28 |
申请号 |
WO2001JP07008 |
申请日期 |
2001.08.13 |
申请人 |
YAMAGUCHI TECHNOLOGY LICENSING ORGANIZATION LTD.;TAKEDA CHEMICAL INDUSTRIES, LTD.;UNUI, MAKOTO;KIMURA, YOSHIHIRO |
发明人 |
UNUI, MAKOTO;KIMURA, YOSHIHIRO |
分类号 |
G01N33/50;A61K45/00;A61P9/04;A61P43/00;C12N1/21;C12N15/09;C12P21/02;C12R1/19;G01N33/15;G01N33/68;(IPC1-7):G01N33/50;G01N33/566 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|